The ability to efficiently isolate antigen-specific monoclonal antibodies (mAbs) has caused explosive growth in our understanding of antibody-mediated immunity, and has enabled the rapid generation of novel therapeutics and diagnostics. However, the traditional monoclonal antibody discovery procedures are labor- and time-intensive and low efficiency.
CD's excellent R&D team has mastered a variety of emerging technologies and can provide customized antibody services for clients based on single B cell cloning technology. https://www.creative-diagn...
CD's excellent R&D team has mastered a variety of emerging technologies and can provide customized antibody services for clients based on single B cell cloning technology. https://www.creative-diagn...
01:53 AM - Apr 10, 2024 (UTC)
No replys yet!
It seems that this publication does not yet have any comments. In order to respond to this publication from ThomasS111 , click on at the bottom under it
Who to follow